M&A Deal Summary |
|
|---|---|
| Date | 2023-05-10 |
| Target | JSS Medical Research |
| Sector | Life Science |
| Buyer(s) | Genesis Drug Discovery & Development |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Sector | Life Science |
Genesis Drug Discovery & Development is a preclinical CRO offering a comprehensive portfolio of services for drug discovery and development. GD3 ensures the efficient development and coordination of unique preclinical programs, from discovery through candidate selection.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| State: Quebec M&A | 1 of 1 |
| Country: Canada M&A | 1 of 1 |
| Year: 2023 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-11-19 |
New England Discovery Partners
Branford, Connecticut, United States New England Discovery Partners LLC is a contract research organization (CRO) specializing in synthetic and medicinal chemistry. New England Discovery Partners is based in Branford, Connecticut. |
Buy | - |